Success Stories: EB-1A Petition Approved in Just 9 Days for Research Assistant in New York in the Field of Translational Medicine
Client’s Testimonial:
"Thank you for your professional work!”
On January 22nd, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Assistant in the Field of Translational Medicine (Approval Notice).
General Field: Translational Medicine
Position at the Time of Case Filing: Research Assistant
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: January 22nd, 2020
Processing Time: 9 days (Premium Processing Requested)
Case Summary:
When our client, a Chinese research assistant with an M.S. in biostatistics, approached North America Immigration Law Group (NAILG) for assistance with EB-1A filing, we first evaluated his credentials. We were impressed with the 36 peer-reviewed journal articles he had published and the 3,571 citations that they had obtained. Moreover, the fact that he had conducted 14 peer reviews further showcased his respected standing in the field.
Based on our client’s aforementioned research achievements, we decided to represent his EB-1A case. After countersigning the legal agreement, we started assembling a well-structured petition that comprised of his scholarly contributions, recommendation letters, and other evidence of his extraordinary ability.
“[Client’s] research has improved the field’s understanding of type-2 diabetes, hypertension, cardiovascular diseases, contributing to the production of more effective treatments. Indeed, he is among the most accomplished researchers working today in the field, and his contributions are in high demand throughout the academic community in the United States and beyond.” This statement was taken from a recommendation letter in support of our client’s EB-1A (Alien of Extraordinary Ability) petition. Several other experts also contributed recommendation letters, all of which provided the USCIS with a clear picture of our client’s expertise in the field of translational medicine.
We also demonstrated that our client’s research addresses some of the United States’ most pressing issues in understanding the genetic etiology of common diseases, e.g. coronary heart disease (leads to heart attack), type 2 diabetes, strokes, and hypertension. We persuaded the USCIS that his research directly aids the American medical and pharmaceutical industries and his achievements are of the utmost importance due to their contributions to human health and well-being.
In addition to carefully assembling the required documents to file the EB-1A petition on behalf of our client, our team has included a customized table for visualization to indicate that our client’s publications have been cited at a much higher rate than those of other researchers in the field, distinguishing him from his peers. The visual presentation of the data has indeed further demonstrated and supported the argument in the petition letter drafted by us.
We truly appreciate our client for trusting us with the preparation of his EB-1A case and for giving us an opportunity to be a part of his success story.